Najmul Hasan Forhad: VWF Concentrates in Modern Hematology and Transfusion Medicine
Najmul Hasan Forhad, Medical Laboratory Technician at Doctors Without Borders, shared on LinkedIn:
”Topic : Immunohematology and Hemostasis
von Willebrand factor (vWF) concentrates is essential in both clinical practice and laboratory medicine, especially when managing patients with von Willebrand disease (vWD) and certain cases of hemophilia A.
Several therapeutic products are commonly used in replacement therapy, including Alphanate, Humate P, Wilate, and recombinant von Willebrand factor preparations.
Alphanate and Humate P are plasma-derived concentrates containing both vWF and factor VIII, providing effective hemostatic support in patients with bleeding disorders.
Humate P is particularly recognized for its predictable vWF:FVIII ratio and is widely used in surgical prophylaxis and severe bleeding management.
Wilate is another plasma-derived product that is highly purified and formulated to closely resemble the physiologic balance between vWF and factor VIII.
It is commonly used for both acute treatment and prophylactic therapy.
Recombinant von Willebrand factor products represent an important advancement in transfusion medicine and hematology.
Because they are not plasma-derived, they minimize the risk of blood-borne pathogen transmission and offer a more targeted therapeutic approach.
From an educational and examination perspective, understanding the differences between plasma-derived and recombinant products, their clinical indications, and their role in different subtypes of vWD remains highly important for laboratory professionals and healthcare practitioners.
Clinical laboratory science continues to play a critical role in bridging diagnostic hematology with evidence-based patient management.”
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 13:16Nathan Connell: Is It Time to Rethink What We Tell Hemophilia B Carriers About Pregnancy?
-
Jul 2, 2026, 13:09Bruce Ovbiagele: WSO SCDKIDS Task Force’s Webinar Sheds Light On Care of Sickle Cell Disease-Related Stroke
-
Jul 2, 2026, 12:55Taraneh G. Farazi: The Latest Stroke Clinician Issue Highlights the Importance of Patient Voices in Dysphagia Care
-
Jul 2, 2026, 12:45Kaveh Mehrvar: The Gut–Brain Axis May Hold New Clues to Stroke Pathophysiology
-
Jul 2, 2026, 12:28Expanding Stroke Education Through Mobile Stroke Clinics – Ethiopia Stroke Foundation
-
Jul 2, 2026, 11:52Praveen Kumar Tirlangi: A New Mechanism of Bleeding in Kyasanur Forest Disease
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis
-
Jul 2, 2026, 11:17Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care
-
Jul 2, 2026, 11:11Safaa Hilal: Improving Postpartum Hemorrhage Outcomes Through Early Warning Scores